SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma

BACKGROUND: Glioma is a fatal tumor originating from the brain, which accounts for most intracranial malignancies. Currently, Immunotherapy has turned into a novel and promising treatment in glioma patients. however, there are still few effective biomarkers to mirror the reaction to immunotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Houshi, Zhang, Anke, Fang, Chaoyou, Zhu, Qingwei, Wang, Wei, Liu, Yibo, Zhang, Zeyu, Wang, Xiaoyu, Yuan, Ling, Xu, Yuanzhi, Shao, Anwen, Lou, Meiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748290/
https://www.ncbi.nlm.nih.gov/pubmed/36531992
http://dx.doi.org/10.3389/fimmu.2022.980378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748290/
https://www.ncbi.nlm.nih.gov/pubmed/36531992
http://dx.doi.org/10.3389/fimmu.2022.980378

Ejemplares similares